| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/05/2011 | US20110105759 Process for producing 1-benzyl-4- [ (5,6-dimethoxy-1-indanone)-2-ylidene] methylpiperidine |
| 05/05/2011 | US20110105758 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroarylcarbocyclic acids |
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105561 Serotonin transporter (sert) inhibitors for the treatment of depression and anxiety |
| 05/05/2011 | US20110105532 Haloalkyl-substituted amides as insecticides and acaricides |
| 05/05/2011 | US20110105530 Organic compounds |
| 05/05/2011 | US20110105506 Diaminoalkane aspartic protease inhibitors |
| 05/05/2011 | US20110105503 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
| 05/05/2011 | US20110105488 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | CA2779108A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | CA2777671A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis |
| 05/04/2011 | EP2316830A2 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors |
| 05/04/2011 | EP2316820A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP2044020B1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| 05/04/2011 | EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/04/2011 | CN102046598A Novel donor-acceptor fluorene scaffolds : a process and uses thereof |
| 05/04/2011 | CN102046595A Substituted 4-aminocyclohexane derivatives |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102039179A Catalytic component for preparing amide and method for preparing amide |
| 05/04/2011 | CN101544598B Diester sebacate (2,2,6,6-tetramethyl-4-hydroxypiperidine) nitroxide radical of high-efficiency polymerization inhibitor and production method thereof |
| 05/04/2011 | CN101544595B production method of stearic acid 2,2,6,6-tetramethyl-4-piperidine ester of light stabilizer |
| 05/04/2011 | CN101203492B Substituted butyrophenone derivatives |
| 05/03/2011 | US7935707 Imidazole derivatives |
| 05/03/2011 | US7935703 Piperazines and piperidines as Mglur5 potentiators |
| 05/03/2011 | CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 04/28/2011 | WO2011048523A1 Process for the manufacture of enantiomerically pure aryloctanoic acids as aliskiren |
| 04/28/2011 | WO2011048409A1 Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2011 | WO2011047981A1 Use of a dialkylphenyl-4-aminopiperidine as agent for the treatment of human perspiration; novel compounds and compositions comprising them |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098324 Prolyl hydroxylase inhibitors |
| 04/28/2011 | US20110098322 Preparation of novel 1,3-substituted ureas as inhibitors of soluble epoxide hydrolase |
| 04/28/2011 | US20110098320 Lactam Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
| 04/28/2011 | US20110098300 Compounds Comprising A Cyclobutoxy Group |
| 04/28/2011 | US20110098281 Benzenesulfonyl Compounds and the Use Thereof |
| 04/28/2011 | US20110098276 Oxycarbamoyl compounds and the use thereof |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | CA2778348A1 Novel compositions for preventing and/or treating degenerative disorders of the central nervous system |
| 04/27/2011 | EP2313370A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 04/27/2011 | EP1307194B2 Fentanyl composition for nasal administration |
| 04/27/2011 | CN102036956A Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 04/27/2011 | CN102036953A Arylsulfonamide-based matrix metalloprotease inhibitors |
| 04/27/2011 | CN102030703A Method for preparing piperidine nitroxide radical polymerization inhibitor |
| 04/27/2011 | CN102028949A Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 04/27/2011 | CN101381477B Hindered amine light stabilizer and synthetic method thereof |
| 04/27/2011 | CN101270076B Method for preparing natural product (3S,9S)-Ciliatamides C |
| 04/27/2011 | CN101182306B Method for synthesizing intermediate of fexofenadine |
| 04/26/2011 | US7932269 Sulfonamides as orexin antagonists |
| 04/26/2011 | US7932252 CCR9 chemokine receptor modulators; treating inflammatory and immune diseases; inhibit the binding of chemokines, such as TECK (thymus-expressed chemokine), to the CCR9 receptor; 1-arylsulfonamido-2-aryl(alkyl)benzene compounds |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/21/2011 | WO2011047190A1 Gamma amino acid building blocks |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011023954A3 Polymorphic forms of manidipine |
| 04/21/2011 | US20110092706 Process for the manufacture of enantiomerically pure aryloctanoic acids as aliskiren |
| 04/21/2011 | US20110092551 Dual-acting imidazole antihypertensive agents |
| 04/21/2011 | US20110092541 Novel compositions for preventing and/or treating degenerative disorders of the central nervous system |
| 04/21/2011 | US20110092536 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 04/21/2011 | US20110092518 Antifouling Compounds And Use Thereof |
| 04/21/2011 | US20110090338 Vehicular rearview mirror system |
| 04/21/2011 | CA2774250A1 C-linked hydroxamic acid derivatives useful as antibacterial agents |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2310365A1 Method for producing n-phenyl-n-(4-piperidinyl)amide salts |
| 04/20/2011 | EP2310364A1 Heterocyclic derivatives as hdac inhibitors |
| 04/20/2011 | EP2310012A1 Process for the preparation of substituted pyrimidine derivatives |
| 04/20/2011 | EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors |
| 04/20/2011 | EP1546100B1 New benzoyl piperidine compounds |
| 04/20/2011 | CN1730475B Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 04/20/2011 | CN102026977A Stabilization of triphenylboron-pyridine |
| 04/20/2011 | CN102026976A Morpholine derivates as antiobesity agents |
| 04/20/2011 | CN102026975A Piperazines as anti-obesity agents |
| 04/20/2011 | CN102020602A Crystal form of lercanidipine hydrochloride and preparation method thereof and crystal form-containing medicinal composition |
| 04/19/2011 | US7928232 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2437813C Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/14/2011 | WO2011044309A1 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | WO2011043445A1 1-substituted-trans-3-(substituted amino)piperidin-4-ol |
| 04/14/2011 | US20110087025 Method for producing 3-amidinophenylalanine derivatives |
| 04/14/2011 | US20110086880 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086818 Methods, compositions, and kits for treating pain and pruritus |
| 04/14/2011 | US20110086311 Base generator, photosensitive resin composition, pattern forming material comprising the photosensitive resin composition, and pattern forming method and article using the photosensitive resin composition |
| 04/14/2011 | US20110086110 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 04/14/2011 | CA2777032A1 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
| 04/13/2011 | EP2308842A1 Pharmaceutical compositions |